Paper · 40458574

Deciphering riddles in molecular subtyping of bladder cancer.

Li Y and 9 others. Asian J Urol, 2025. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Deciphering riddles in molecular subtyping of bladder cancer. Papers, record 40458574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40458574

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Deciphering riddles in molecular subtyping of bladder cancer.; PubMed
Journal: Asian J Urol; PubMed
Year: 2025; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/40458574/; PubMed
DOI: https://doi.org/10.1016/j.ajur.2024.09.006; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC12126956/; PubMed
The journal: https://conductscience.org/library/journal-index/101699720; PubMed
Citations, by iCite: 5; iCite
Relative citation ratio, by iCite: 1.31, provisional; iCite
Revised in PubMed: 2025-06-05; PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Li Y	Yuxiao
2	Huang S	Suyuelin
3	Ju W	Wenlong
4	Lu D	Dingheng
5	Sun J	Jiazhu
6	Zhan W	Weitao
7	Niu X	Xinyang
8	Shi Y	Yuchen
9	Yu K	Kai
10	Liu B	Ben

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References129

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	20,406,976	Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.	Cancer Res	2010	https://conductscience.org/library/papers/20406976	PubMed
2	12,944,571	Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.	N Engl J Med	2003	https://conductscience.org/library/papers/12944571	PubMed
3	29,848,605	Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.	Cancer Discov	2018	https://conductscience.org/library/papers/29848605	PubMed
4	25,009,231	EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.	Sci Transl Med	2014	https://conductscience.org/library/papers/25009231	PubMed
5	27,321,955	Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.	Cancer Cell	2016	https://conductscience.org/library/papers/27321955	PubMed
6	33,863,885	An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.	Nat Commun	2021	https://conductscience.org/library/papers/33863885	PubMed
7	37,380,560	Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer.	Eur Urol	2024	https://conductscience.org/library/papers/37380560	PubMed
8	30,343,614	Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study.	J Clin Oncol	2018	https://conductscience.org/library/papers/30343614	PubMed
9	29,443,960	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	Nature	2018	https://conductscience.org/library/papers/29443960	PubMed
10	35,147,837	EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors.	Mol Imaging Biol	2022	https://conductscience.org/library/papers/35147837	PubMed

1 to 10 of 129

See all 129 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMID	Title	Journal	Year	In Papers	Source
42,959,047	Association of MAGEA4 expression with molecular and immune subtypes and clinical outcomes in recurrent bladder cancer.	Front Oncol	2026	https://conductscience.org/library/papers/42959047	PubMed
42,373,686	Integrating whole-genome bisulfite sequencing and TCGA data reveals methylation patterns associated with the MTHFR 677 C > T Variant.	Sci Rep	2026	https://conductscience.org/library/papers/42373686	PubMed
42,369,179	Complete pathological response in patients with bladder cancer: predictors and outcomes.	Ther Adv Urol	2026	https://conductscience.org/library/papers/42369179	PubMed
42,295,562	Machine learning-based identification of basement membrane-related signature to predict recurrence and immunotherapy benefit in bladder cancer.	Immunol Res	2026	https://conductscience.org/library/papers/42295562	PubMed
42,241,992	Multi-omics analysis identifies CKLF as a promoter for HCC progression by regulating the AKT, ERK pathways, and infiltrating immune cells.	Transl Oncol	2026	https://conductscience.org/library/papers/42241992	PubMed
41,751,537	Genomic Subtypes and Computational Biomarkers in Non-Muscle-Invasive Bladder Cancer Guiding Optimal Timing of Radical Cystectomy and BCG Response Prediction.	Genes (Basel)	2026	https://conductscience.org/library/papers/41751537	PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
EGFR	1,956	PubTator's text mining	https://conductscience.org/library/genes/1956	NCBI Gene
FGFR3	2,261	PubTator's text mining	https://conductscience.org/library/genes/2261	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40458574

GET https://conductscience.org/api/papers/v1/40458574/references?page=2

API reference For AI assistants